IRIX
IRIDEX CORP
NASDAQ · Healthcare · Medical - Devices · US
$0.77
−5.48%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$0.81
From 52W high−50.64%
Volume40768.00
Market cap$13.52M
P/E (TTM)—
P/S (TTM)0.3x
Div yield—
Key dataOct 19, 2026
Open
$0.81
From 52W high
−50.64%
Volume
40768.00
Market cap
$13.52M
ValuationView details →
P/E (Fwd)
38.5x
EV/EBITDA
−11.1x
P/E (TTM)
—
RSI (14)
55.7
MomentumView details →
1D Return
−5.48%
YTD Return
−29.82%
SummaryUpdated Jul 1, 2026
IRIDEX Corporation (NASDAQ:IRIX) is a specialized ophthalmic medical technology company founded in 1989 and headquartered in Mountain View, California. The company went public in 1996 and has established itself as a provider of therapeutic laser systems and related devices for treating sight-threatening eye diseases. IRIDEX focuses primarily on two major areas of ophthalmology: glaucoma and retinal disorders, serving eye care professionals worldwide through both direct sales and international distribution networks.
Similar companies
Latest newsMore news →
Iridex completed the relocation of its manufacturing facility to San Jose, California, expecting about $600,000 in annualized cost savings.14d agoIRIDEX Corp received a notice from NASDAQ on 2026-08-27 stating it no longer meets the minimum bid price requirement under Rule 5550(a)(2), and has until 2027-02-23 to regain compliance.47d ago